Kourakis A, Dozi-Vassiliades J, Hatzitheodoridou P, Tsiouris J, Mourelatos D
Basic Life Sci. 1984;29 Pt B:907-14. doi: 10.1007/978-1-4684-4892-4_30.
The effect of diphylline (DP) or (1,2-dihydroxy-3-propyl)-theophylline and theobromine (TB) on sister chromatid exchange (SCE) rates induced in vitro by cytosine arabinoside (AraC) was studied in normal human lymphocytes. The combined treatments with AraC plus DP or TB showed the potentiating ability of the latter drugs. In a combined in vivo and in vitro study, lymphocytes taken from 14 patients suffering from various types of cancer who had been given Cytoxan (5 patients) or AraC (9 patients) by injection 3 hr before and then treated with DP or TB in vitro were found to have synergistically increased exchange rates. This has implications for interpreting the repair processes involved and for monitoring drug combinations that synergistically damage DNA in vivo and in vitro.
在正常人淋巴细胞中研究了二羟丙茶碱(DP)或(1,2 - 二羟基 - 3 - 丙基) - 茶碱与可可碱(TB)对阿糖胞苷(AraC)体外诱导的姐妹染色单体交换(SCE)率的影响。AraC与DP或TB联合处理显示出后两种药物的增强作用。在一项体内和体外联合研究中,发现从14例患有各种类型癌症的患者中采集的淋巴细胞,这些患者在注射环磷酰胺(5例患者)或阿糖胞苷(9例患者)3小时前接受注射,然后在体外接受DP或TB处理,其交换率协同增加。这对于解释所涉及的修复过程以及监测在体内和体外协同损伤DNA的药物组合具有重要意义。